Praha\/Bohumil, \u010cesk\u00e1 republika, 12. \u010dervna 2026 \u2013 D\u00e1nsk\u00e1 farmaceutick\u00e1 spole\u010dnost Novo Nordisk investuje v\u00edce ne\u017e 8 miliard korun do v\u00fdrobn\u00edho z\u00e1vodu v Bohumili ve St\u0159edo\u010desk\u00e9m kraji. Jde o jednu z nejv\u00fdznamn\u011bj\u0161\u00edch investic do inovativn\u00ed farmaceutick\u00e9 v\u00fdroby v \u010cesk\u00e9 republice. Spole\u010dnost Novo Nordisk si Bohumil vybrala d\u00edky vysoce kvalifikovan\u00e9 pracovn\u00ed s\u00edle a dlouholet\u00e9 tradici v\u00fdroby protein\u016f a navazuje tak na v\u00edce ne\u017e 30 let sv\u00e9ho p\u016fsoben\u00ed na \u010desk\u00e9m trhu.<\/p>\n\n\n\n
Z\u00e1vod v Bohumili za\u010dne vyr\u00e1b\u011bt ji\u017e tento m\u011bs\u00edc. Po \u00fasp\u011b\u0161n\u00e9m dokon\u010den\u00ed testovac\u00ed f\u00e1ze se v prvn\u00ed etap\u011b zam\u011b\u0159\u00ed na v\u00fdrobu podp\u016frn\u00fdch protein\u016f pro l\u00e9ky nov\u00e9 generace ur\u010den\u00e9 k l\u00e9\u010db\u011b diabetu a obezity. Dv\u011b z nejpal\u010div\u011bj\u0161\u00edch zdravotn\u00edch v\u00fdzev sou\u010dasnosti postihuj\u00ed miliony lid\u00ed v \u010cesk\u00e9 republice i po cel\u00e9m sv\u011bt\u011b.
\u201eObezita a cukrovka pat\u0159\u00ed mezi nejz\u00e1va\u017en\u011bj\u0161\u00ed chronick\u00e1 onemocn\u011bn\u00ed. Pokud chceme pacient\u016fm dlouhodob\u011b pom\u00e1hat, mus\u00edme d\u00e1l investovat do v\u00fdzkumu a z\u00e1rove\u0148 l\u00e9pe spolupracovat nap\u0159\u00ed\u010d cel\u00fdm zdravotn\u00edm syst\u00e9mem,\u201c \u0159\u00edk\u00e1 prof. MUDr. Martin Pr\u00e1zn\u00fd, p\u0159edseda \u010cesk\u00e9 diabetologick\u00e9 spole\u010dnosti.<\/p>\n\n\n\n
Z\u00e1vod v Bohumili je sou\u010d\u00e1st\u00ed mezin\u00e1rodn\u00ed v\u00fdrobn\u00ed s\u00edt\u011b spole\u010dnosti Novo Nordisk a p\u0159isp\u00edv\u00e1 k tomu, aby se d\u016fle\u017eit\u00e9 l\u00e9ky dostaly k pacient\u016fm po cel\u00e9m sv\u011bt\u011b v\u010das a v dostate\u010dn\u00e9m mno\u017estv\u00ed. Aktu\u00e1ln\u011b zde pracuje p\u0159ibli\u017en\u011b 300 lid\u00ed. Z\u00e1vod spolupracuje s m\u00edstn\u00edmi dodavateli a p\u0159isp\u00edv\u00e1 do ve\u0159ejn\u00fdch rozpo\u010dt\u016f prost\u0159ednictv\u00edm da\u0148ov\u00fdch p\u0159\u00edjm\u016f. <\/p>\n\n\n\n
\u201eTakov\u00e9 investice maj\u00ed skute\u010dn\u00fd smysl. P\u0159in\u00e1\u0161ej\u00ed kvalifikovan\u00e1 pracovn\u00ed m\u00edsta, posiluj\u00ed postaven\u00ed \u010cesk\u00e9 republiky v oblasti modern\u00edch technologi\u00ed a z\u00e1rove\u0148 pom\u00e1haj\u00ed rozv\u00edjet l\u00e9\u010dbu nemoc\u00ed, kter\u00e9 p\u0159edstavuj\u00ed jednu z nejv\u011bt\u0161\u00edch zdravotn\u00edch v\u00fdzev sou\u010dasnosti. Jsem r\u00e1d, \u017ee se \u010cesk\u00e9 republice poda\u0159ilo z\u00edskat takto v\u00fdznamnou investici spole\u010dnosti Novo Nordisk a \u017ee se na\u0161e zem\u011b st\u00e1v\u00e1 sou\u010d\u00e1st\u00ed v\u00fdvoje a v\u00fdroby l\u00e9\u010div, kter\u00e1 pom\u00e1haj\u00ed zlep\u0161ovat kvalitu \u017eivota lid\u00ed a lidsk\u00e9 \u017eivoty i zachra\u0148ovat,\u201d uvedl premi\u00e9r Andrej Babi\u0161.<\/p>\n\n\n\n
\u201eNa\u0161\u00ed prioritou je zajistit, aby se takov\u00e9to investice do inovac\u00ed prom\u00edtly do lep\u0161\u00ed prevence, v\u010dasn\u011bj\u0161\u00ed diagnostiky a \u00fa\u010dinn\u011bj\u0161\u00ed l\u00e9\u010dby pacient\u016f. Vysoce si cen\u00edme siln\u00e9 spolupr\u00e1ce s partnery, kte\u0159\u00ed pom\u00e1haj\u00ed rozv\u00edjet zdravotn\u00ed p\u00e9\u010di a zlep\u0161ovat v\u00fdsledky l\u00e9\u010dby lid\u00ed \u017eij\u00edc\u00edch s chronick\u00fdmi onemocn\u011bn\u00edmi,\u201c uvedl ministr zdravotnictv\u00ed Adam Vojt\u011bch a zd\u016fraznil, \u017ee pr\u00e1v\u011b podpora v\u00fdzkumu, modern\u00edch technologi\u00ed a dostupnosti inovativn\u00edch postup\u016f je kl\u00ed\u010dov\u00e1 pro zvy\u0161ov\u00e1n\u00ed kvality \u017eivota pacient\u016f a udr\u017eitelnost zdravotn\u00edho syst\u00e9mu.
Novo Nordisk s.r.o. Karolinsk\u00e1 706\/3
Podle m\u00edstop\u0159edsedy vl\u00e1dy a ministra pr\u016fmyslu a obchodu Karla Havl\u00ed\u010dka m\u00e1 investice do v\u00fdroby v Bohumili v\u00fdznam tak\u00e9 v sou\u010dasn\u00e9m geopolitick\u00e9m kontextu. \u201ePosilov\u00e1n\u00ed v\u00fdrobn\u00edch kapacit v Evrop\u011b pom\u00e1h\u00e1 sni\u017eovat z\u00e1vislost na glob\u00e1ln\u00edch dodavatelsk\u00fdch \u0159et\u011bzc\u00edch a p\u0159isp\u00edv\u00e1 ke stabiln\u011bj\u0161\u00ed v\u00fdrob\u011b l\u00e9\u010div,\u201c uvedl Karel Havl\u00ed\u010dek.
V\u00fdznam investice pro farmaceutick\u00fd pr\u016fmysl zd\u016fraz\u0148uje tak\u00e9 gener\u00e1ln\u00ed \u0159editelka Novo Nordisk \u010cesk\u00e1 republika Anna Grefkowicz: \u201eTato investice ukazuje, \u017ee Novo Nordisk chce b\u00fdt dlouhodobou sou\u010d\u00e1st\u00ed \u010desk\u00e9ho zdravotnictv\u00ed. Krom\u011b v\u00fdvoje a dod\u00e1v\u00e1n\u00ed inovativn\u00edch l\u00e9k\u016f pro pacienty se z\u00e1va\u017en\u00fdmi chronick\u00fdmi onemocn\u011bn\u00edmi se zam\u011b\u0159ujeme na podporu pacient\u016f, rozvoj klinick\u00e9ho v\u00fdzkumu a posilov\u00e1n\u00ed postaven\u00ed \u010cesk\u00e9 republiky v oblasti modern\u00ed farmaceutick\u00e9 v\u00fdroby.\u201c
Spole\u010dnost Novo Nordisk koupila z\u00e1vod v Bohumili od americk\u00e9 farmaceutick\u00e9 spole\u010dnosti Novavax na konci roku 2024 za 4,8 miliardy korun a n\u00e1sledn\u011b investovala dal\u0161\u00ed p\u0159ibli\u017en\u011b 3,5 miliardy korun do jeho modernizace.
\u201eZ\u00e1vod jsme p\u0159estav\u011bli a uzp\u016fsobili tak, aby spl\u0148oval glob\u00e1ln\u00ed v\u00fdrobn\u00ed standardy spole\u010dnosti Novo Nordisk, v\u010detn\u011b z\u00e1sadn\u00edch modernizac\u00ed v\u00fdrobn\u00edch technologi\u00ed, digit\u00e1ln\u00ed infrastruktury a syst\u00e9m\u016f kvality,\u201c vysv\u011btlil Jakub Kronovetr, gener\u00e1ln\u00ed \u0159editel spole\u010dnosti Novo Nordisk Production Czech.<\/p>\n\n\n\n
O spole\u010dnosti Novo Nordisk
Novo Nordisk je p\u0159edn\u00ed glob\u00e1ln\u00ed farmaceutick\u00e1 spole\u010dnost zalo\u017een\u00e1 v roce 1923 se s\u00eddlem v D\u00e1nsku. Zam\u011b\u0159uje se na v\u00fdvoj a v\u00fdrobu l\u00e9\u010div pro pacienty se z\u00e1va\u017en\u00fdmi chronick\u00fdmi onemocn\u011bn\u00edmi, zejm\u00e9na na diabetes, obezitu a vz\u00e1cn\u00e1 onemocn\u011bn\u00ed. S pomoc\u00ed v\u011bdeck\u00fdch inovac\u00ed usiluje o zlep\u0161en\u00ed prevence, l\u00e9\u010dby a kvality \u017eivota pacient\u016f po cel\u00e9m sv\u011bt\u011b. Spole\u010dnost zam\u011bstn\u00e1v\u00e1 p\u0159ibli\u017en\u011b 67 900 lid\u00ed v 80 zem\u00edch a sv\u00e9 produkty dod\u00e1v\u00e1 na trh ve zhruba 170 zem\u00edch sv\u011bta.
V \u010cesk\u00e9 republice p\u016fsob\u00ed Novo Nordisk od roku 1991 a jej\u00ed l\u00e9ky zde v sou\u010dasnosti vyu\u017e\u00edv\u00e1 p\u0159ibli\u017en\u011b 200 tis\u00edc pacient\u016f. Spole\u010dnost aktu\u00e1ln\u011b realizuje 15 klinick\u00fdch studi\u00ed, kter\u00e9 p\u0159isp\u00edvaj\u00ed k rozvoji medic\u00ednsk\u00e9ho pozn\u00e1n\u00ed a z\u00e1rove\u0148 pacient\u016fm umo\u017e\u0148uj\u00ed p\u0159\u00edstup k nejmodern\u011bj\u0161\u00edm l\u00e9\u010debn\u00fdm postup\u016fm.
V\u00edce informac\u00ed naleznete na www.novonordisk.cz.<\/p>\n","protected":false},"excerpt":{"rendered":"
Praha\/Bohumil, \u010cesk\u00e1 republika, 12. \u010dervna 2026 \u2013 D\u00e1nsk\u00e1 farmaceutick\u00e1 spole\u010dnost Novo Nordisk investuje v\u00edce ne\u017e 8 miliard korun do v\u00fdrobn\u00edho z\u00e1vodu v Bohumili ve St\u0159edo\u010desk\u00e9m […]<\/a><\/p>\n<\/div>","protected":false},"author":1,"featured_media":14126,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-64100","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-zpravy"],"_links":{"self":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/64100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=64100"}],"version-history":[{"count":0,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/64100\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/media\/14126"}],"wp:attachment":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=64100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=64100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=64100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}